97 related articles for article (PubMed ID: 2868453)
21. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
[TBL] [Abstract][Full Text] [Related]
22. Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome.
Ramsay JA; Kovacs K; Asa SL; Pike MJ; Thorner MO
Cancer; 1988 Jul; 62(2):445-50. PubMed ID: 2898285
[TBL] [Abstract][Full Text] [Related]
23. Somatostatinoma syndrome is clinically diagnosed.
Am Fam Physician; 1979 Dec; 20(6):140, 145. PubMed ID: 229723
[No Abstract] [Full Text] [Related]
24. [Endocrine tumors of the gastrointestinal and pancreatic systems. Multiple endocrine adenoma from another viewpoint].
Klempa I; Helmstädter V; Feurle G; Röttger P
Chirurg; 1980 May; 51(5):321-9. PubMed ID: 6105939
[TBL] [Abstract][Full Text] [Related]
25. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
[TBL] [Abstract][Full Text] [Related]
26. Morphology of a GHRH producing pancreatic islet cell tumour causing acromegaly.
Saeger W; Schulte HM; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1986; 409(4):547-54. PubMed ID: 3016979
[TBL] [Abstract][Full Text] [Related]
27. HPLC analysis of somatostatin peptides secreted by a rat pancreatic endocrine cell line (RINT3): stimulation studies.
Lherisson C; Estival A; Pradayrol L; Vaysse N
Horm Res; 1989; 32(1-3):67-70. PubMed ID: 2575579
[TBL] [Abstract][Full Text] [Related]
28. Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery.
Borson-Chazot F; Garby L; Raverot G; Claustrat F; Raverot V; Sassolas G;
Ann Endocrinol (Paris); 2012 Dec; 73(6):497-502. PubMed ID: 23122576
[TBL] [Abstract][Full Text] [Related]
29. Acromegaly caused by growth hormone releasing hormone (GHRH) secreting tumor in multiple endocrine neoplasia (MEN-1).
Saleem TF; Santhanam P; Hamoudeh E; Hassan T; Faiz S
W V Med J; 2012; 108(2):26-30. PubMed ID: 22655432
[TBL] [Abstract][Full Text] [Related]
30. Endocrine tumours of the pancreas: review and recent advances.
Mullan MH; Gauger PG; Thompson NW
ANZ J Surg; 2001 Aug; 71(8):475-82. PubMed ID: 11504292
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future.
Öberg K; Lamberts SW
Endocr Relat Cancer; 2016 Dec; 23(12):R551-R566. PubMed ID: 27697899
[TBL] [Abstract][Full Text] [Related]
32. [Pancreatic secreting glucagonoma: inhibitory effect of somatostatin-14 (author's transl)].
Vinel JP; Pradére B; Voigt JJ; Pradayrol L; Pascal JP
Gastroenterol Clin Biol; 1981 Dec; 5(12):1155-9. PubMed ID: 6119270
[No Abstract] [Full Text] [Related]
33. Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor.
Melmed S; Ezrin C; Kovacs K; Goodman RS; Frohman LA
N Engl J Med; 1985 Jan; 312(1):9-17. PubMed ID: 2981107
[No Abstract] [Full Text] [Related]
34. [Acromegaly due to a pancreatic tumor producing growth hormone releasing hormone: clinical picture and morphology].
Donhuijsen K; Schulte HM; Schmidt U; Metz K; Benker G
Schweiz Med Wochenschr; 1986 May; 116(18):615-21. PubMed ID: 3086973
[TBL] [Abstract][Full Text] [Related]
35. Pathology of the endocrine pancreas.
Heitz PU; Kasper M; Polak JM; Klöppel G
J Histochem Cytochem; 1979 Oct; 27(10):1401-2. PubMed ID: 229158
[TBL] [Abstract][Full Text] [Related]
36. [A case of multiple endocrine neoplasia, type 1, with parathyroid adenoma, multinodular adrenal cortical hyperplasia, islet cell tumor and hyperplasia of thyroid with concomitant hypersecretion of gastrin and total glucagon-like immunoreactivity].
Shigematsu S; Shimoyama N; Sato Y; Horita M; Oribe Y; Ono J; Takaki R; Ishimatsu T; Kodama M; Iwashita K
Nihon Naika Gakkai Zasshi; 1989 Mar; 78(3):357-62. PubMed ID: 2567324
[No Abstract] [Full Text] [Related]
37. Tumors of the endocrine pancreas.
Friesen SR
N Engl J Med; 1982 Mar; 306(10):580-90. PubMed ID: 6120456
[No Abstract] [Full Text] [Related]
38. Clinical aspects of gastrointestinal hormones.
Lamers CB
Neth J Med; 1978; 21(2):77-82. PubMed ID: 206847
[No Abstract] [Full Text] [Related]
39. Growth-hormone-releasing factor immunoreactivity in human endocrine tumors.
Bostwick DG; Quan R; Hoffman AR; Webber RJ; Chang JK; Bensch KG
Am J Pathol; 1984 Nov; 117(2):167-70. PubMed ID: 6093542
[TBL] [Abstract][Full Text] [Related]
40. Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors.
Wynick D; Williams SJ; Bloom SR
N Engl J Med; 1988 Sep; 319(10):605-7. PubMed ID: 2842676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
